China Limits Some Travel as Singapore Reports Virus Case

The transcript discusses China's increased transparency since the 2003 SARS outbreak and the challenges posed by increased travel and a larger services sector in managing new outbreaks. It highlights the pharmaceutical industry's focus on non-infectious diseases and the limited number of major drugmakers with vaccine units. The potential economic impact of a new outbreak is compared to the SARS episode, with a focus on GDP changes. The difficulty in modeling virus spread due to limited information is also addressed.

In what ways has the Chinese economy changed since the SARS outbreak in 2003?

What impact did the SARS outbreak have on China's GDP in 2003?

How might the current situation with the potential pandemic differ from the SARS outbreak?